Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

"DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes.

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

If you’re the kind of person who Googles your health symptoms (no judgment!) you may realize that these experiences could ...

Since my shock diagnosis of type 1 diabetes three and a half years ago, one of the most transformational elements of the ...

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board ...

Finland in 2013, makes a smart ring that helps customers track sleep, activity, stress and heart health among other features. Dexcom makes continuous glucose monitoring devices, including a ...

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...